SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-003246
Filing Date
2023-03-09
Accepted
2023-03-09 07:00:20
Documents
13
Period of Report
2023-03-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K thrx-20230309x8k.htm   iXBRL 8-K 42621
2 EX-99.1 thrx-20230309xex99d1.htm EX-99.1 140398
  Complete submission text file 0001558370-23-003246.txt   316487

Data Files

Seq Description Document Type Size
3 EX-101.SCH thrx-20230309.xsd EX-101.SCH 3123
4 EX-101.LAB thrx-20230309_lab.xml EX-101.LAB 15917
5 EX-101.PRE thrx-20230309_pre.xml EX-101.PRE 10315
7 EXTRACTED XBRL INSTANCE DOCUMENT thrx-20230309x8k_htm.xml XML 4807
Mailing Address 314 MAIN STREET, SUITE 04-200 CAMBRIDGE MA 02142
Business Address 314 MAIN STREET, SUITE 04-200 CAMBRIDGE MA 02142 (857) 400-9491
Theseus Pharmaceuticals, Inc. (Filer) CIK: 0001745020 (see all company filings)

IRS No.: 830712806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40869 | Film No.: 23718128
SIC: 2834 Pharmaceutical Preparations